November 9, 2011 (Chinavestor) Chinese medical equipment maker, Mindray Medical (NYSE:MR) fell over 10% yesterday before recovering some of those losses later the trading day. It is easy to see why the plunge: lack of revenue and net income growth. Even a $100 million share buyback program, announced the same day, failed to lift investor sentiment.
Mindray Medical (NYSE:MR) reported revenue growth of 28.9% from last year but a 0.5% growth from last quarter. Sales in China were strong but Europe, its largest export market, remains a trouble spot.
Margins are under pressure in China due to cut throat competition. That is a problem for the company going forward for its net margins fell from 21.4% to 17.1% year-over-year.
Overall the company is well positioned for the mid-term but upside looks limited for the short run unless Europe puts its house in order.
September 29, 2011 (Chinavestor) Our analysis revealed that among all Chinese sectors, health care did best in September. The good news is that the bounce back was supported by money flows. This bode...
November 4, 2010 (Chinavestor) Mindray Medical (NYSE:MR), a mid-size Chinese medical equipment maker, opened 4% higher but fell back to yesterdays' close after 30 minutes of trading on Thursday. The ...
October 20, 2010 (Chinavestor) I had a chance to sit down with Ms. Julie Chen, Managing Director and Senior Research Analyst of Hudson Securities, on October 13 to talk about three hot Chinese sector...
June 16, 2010 (Chinavestor) Chinadex International (NASDAQ:CHDX), a Chinese health-care service provider, reported quarterly results for the three months ended March 31, 2010. This marked 2010 fo...
